ArticleHaematologica2018

The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis.

Mathias Schneeweiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.